By Professor Dedee Frances Murrell

Journal articles

Fölster-Holst R; Torrelo A; Das K; Murrell DF; Patil A; Rahmat Pour Rokni G; Grabbe S; Staubach P; Sohn A; Goldust M, 2022, 'Biological medication in atopic dermatitis', Expert Opinion on Biological Therapy, 22, pp. 643 - 649, http://dx.doi.org/10.1080/14712598.2022.2026920

Wu D; Daniel BS; Lai AJX; Wong N; Lim DKA; Murrell DF; Lim BXH; Mehta JS; Lim CHL, 2022, 'Proposed management algorithm for dupilumab-associated ocular side effects: a collaborative effort between dermatologists and ophthalmologists', Journal of the European Academy of Dermatology and Venereology, http://dx.doi.org/10.1111/jdv.18397

Wilson B; Sun M; Revankar R; Murrell D; Murase J, 2022, 'Three-Year Assessment of Diversity and Skin of Color Content in Dermatitis', Dermatitis, 33, pp. E6 - E7, http://dx.doi.org/10.1097/DER.0000000000000813

Khosrotehrani K; Murrell D; Veysey E; Tong P; Bennett H; Mar V; Soyer HP, 2022, 'Training and Retaining Physician‒Scientists in Dermatology: Australia', JID Innovations, 2, http://dx.doi.org/10.1016/j.xjidi.2021.100074

Hall R; Culton DA; Liu Z; Ujiie H; Schmidt E; Murrell D; Stoykov I; Verheesen P; Borradori L; Joly P, 2022, '070 Treating Bullous Pemphigoid by Inhibiting FcRn: A Phase 2/3 Trial with Efgartigimod', Journal of Investigative Dermatology, 142, pp. S192 - S192, http://dx.doi.org/10.1016/j.jid.2022.09.079

Murrell DF; Bruckner AL; Davis C; Maher L; Cunningham T; Summeray M, 2022, '34650 Correlation between wound burden and procedural pain in patients with EB ≥4 years of age: An exploratory analysis from the EASE study', Journal of the American Academy of Dermatology, 87, pp. AB152 - AB152, http://dx.doi.org/10.1016/j.jaad.2022.06.641

Lee LW; Kern JS; Murrell D; Löwe S; Maher L; Cunnigham T, 2022, 'LB970 Effect of Oleogel-S10 (birch triterpenes) on dressing change frequency and wound infection in epidermolysis bullosa: Analysis from the EASE study', Journal of Investigative Dermatology, 142, pp. B22 - B22, http://dx.doi.org/10.1016/j.jid.2022.05.992

Chogani F; Parvizi MM; Murrell DF; Handjani F, 2021, 'Assessing the quality of life in the families of patients with epidermolysis bullosa: The mothers as main caregivers', International Journal of Women's Dermatology, 7, pp. 721 - 726, http://dx.doi.org/10.1016/j.ijwd.2021.08.007

Revankar R; Murrell DF; Murase JE, 2021, 'Shedding light on the impact of hidradenitis suppurativa on women and their families: A focus of the International Journal of Women's Dermatology', International Journal of Women's Dermatology, 7, pp. 661 - 663, http://dx.doi.org/10.1016/j.ijwd.2021.08.005

Zeng FAP; Murrell DF, 2021, 'State-of-the-art review of human autoimmune blistering diseases (AIBD)', Veterinary Dermatology, 32, pp. 524 - e145, http://dx.doi.org/10.1111/vde.13008

Kossard S; Sheriff T; Murrell D, 2021, 'T-Cell-Driven Fibroinflammation Inducing Follicular Dedifferentiation in Alopecia Areata and IgG4-Modified Disease', American Journal of Dermatopathology, 43, pp. 955 - 961, http://dx.doi.org/10.1097/DAD.0000000000001992

Ho G; Murrell DF, 2021, 'Angiosarcoma presenting as unexplainable unilateral leg pain and purpuric toes', Medical Journal of Australia, 215, pp. 456, http://dx.doi.org/10.5694/mja2.51310

Kang M; Chen JSC; Radjenovic M; Yang A; Feng GHY; Murrell DF, 2021, 'An analysis of the prevalence of osteoporosis and osteopenia in patients with epidermolysis bullosa: A cross-sectional study', Experimental Dermatology, 30, pp. 1675 - 1685, http://dx.doi.org/10.1111/exd.14252

Sun MD; Wilson BN; Weitzman S; Ren J; Murrell DF; Murase JE, 2021, 'Assessment of published literature regarding skin of color in Pediatric Dermatology', Pediatric Dermatology, 38, pp. 1604 - 1605, http://dx.doi.org/10.1111/pde.14823

Sun MD; Wilson BN; Zhou RZ; Murrell DF; Murase JE, 2021, 'Evaluating diversity in Clinics in Dermatology: Diversity in clinics in dermatology: M. Sun et al.', Clinics in Dermatology, 39, pp. 1064 - 1066, http://dx.doi.org/10.1016/j.clindermatol.2021.07.010

Eng VA; Solis DC; Gorell ES; Choi S; Nazaroff J; Li S; de Souza MP; Murrell DF; Marinkovich MP; Tang JY, 2021, 'Patient-reported outcomes and quality of life in recessive dystrophic epidermolysis bullosa: A global cross-sectional survey', Journal of the American Academy of Dermatology, 85, pp. 1161 - 1167, http://dx.doi.org/10.1016/j.jaad.2020.03.028

Schmidt E; Rashid H; Marzano AV; Lamberts A; Di Zenzo G; Diercks GFH; Alberti-Violetti S; Barry RJ; Borradori L; Caproni M; Carey B; Carrozzo M; Cianchini G; Corrà A; Dikkers FG; Feliciani C; Geerling G; Genovese G; Hertl M; Joly P; Meijer JM; Mercadante V; Murrell DF; Ormond M; Pas HH; Patsatsi A; Rauz S; van Rhijn BD; Roth M; Setterfield J; Zillikens D; C.Prost ; Zambruno G; Horváth B; Caux F, 2021, 'European Guidelines (S3) on diagnosis and management of mucous membrane pemphigoid, initiated by the European Academy of Dermatology and Venereology – Part II', Journal of the European Academy of Dermatology and Venereology, 35, pp. 1926 - 1948, http://dx.doi.org/10.1111/jdv.17395

Murrell DF; Patsatsi A; Stavropoulos P; Baum S; Zeeli T; Kern JS; Roussaki-Schulze AV; Sinclair R; Bassukas ID; Thomas D; Neale A; Arora P; Caux F; Werth VP; Gourlay SG; Joly P, 2021, 'Proof of concept for the clinical effects of oral rilzabrutinib, the first Bruton tyrosine kinase inhibitor for pemphigus vulgaris: the phase II BELIEVE study*', British Journal of Dermatology, 185, pp. 745 - 755, http://dx.doi.org/10.1111/bjd.20431

Wilson BN; Sun M; Ashbaugh AG; Ohri S; Yeh C; Murrell DF; Murase JE, 2021, 'Assessment of skin of color and diversity and inclusion content of dermatologic published literature: An analysis and call to action', International Journal of Women's Dermatology, 7, pp. 391 - 397, http://dx.doi.org/10.1016/j.ijwd.2021.04.001

Murase JE; Murrell DF, 2021, 'Embracing diversity in dermatology: Creation of a culture of inclusion in dermatologic publishing', International Journal of Women's Dermatology, 7, pp. 371 - 377, http://dx.doi.org/10.1016/j.ijwd.2021.08.001

Rashid H; Lamberts A; Borradori L; Alberti-Violetti S; Barry RJ; Caproni M; Carey B; Carrozzo M; Caux F; Cianchini G; Corrà A; Diercks GFH; Dikkers FG; Di Zenzo G; Feliciani C; Geerling G; Genovese G; Hertl M; Joly P; Marzano AV; Meijer JM; Mercadante V; Murrell DF; Ormond M; Pas HH; Patsatsi A; Prost C; Rauz S; van Rhijn BD; Roth M; Schmidt E; Setterfield J; Zambruno G; Zillikens D; Horváth B, 2021, 'European guidelines (S3) on diagnosis and management of mucous membrane pemphigoid, initiated by the European Academy of Dermatology and Venereology – Part I', Journal of the European Academy of Dermatology and Venereology, 35, pp. 1750 - 1764, http://dx.doi.org/10.1111/jdv.17397

Clarke RA; Fang Z; Murrell D; Sherriff T; Eapen V, 2021, 'Gdf6 knockdown in a family with multiple synostosis syndrome and speech impairment', Genes, 12, http://dx.doi.org/10.3390/genes12091354

Fulchand S; Harris N; Li S; Barriga M; Gorell E; De Souza M; Murrell D; Marinkovich MP; Krishna Yenamandra V; Tang JY, 2021, 'Patient-reported outcomes and quality of life in dominant dystrophic epidermolysis bullosa: A global cross-sectional survey', Pediatric Dermatology, 38, pp. 1198 - 1201, http://dx.doi.org/10.1111/pde.14802

Su JC; Murashkin N; Wollenberg A; Svensson Å; Chernyshov P; Lio P; Murrell D; Nosbaum A; Faure S; Mery S; Stalder JF, 2021, 'Pharmacist recommendations regarding topical steroid use may contradict the standard of care in atopic dermatitis: An international, cross-sectional study', JAAD International, 4, pp. 13 - 14, http://dx.doi.org/10.1016/j.jdin.2021.04.005

Lin G; Murase JE; Murrell DF; Godoy LDC; Grant-Kels JM, 2021, 'The impact of gender in mentor–mentee success: Results from the Women's Dermatologic Society Mentorship Survey', International Journal of Women's Dermatology, 7, pp. 398 - 402, http://dx.doi.org/10.1016/j.ijwd.2021.04.010

Patsatsi A; Murrell DF, 2021, 'Bruton Tyrosine Kinase Inhibition and Its Role as an Emerging Treatment in Pemphigus', Frontiers in Medicine, 8, http://dx.doi.org/10.3389/fmed.2021.708071

Ho G; Blake SC; Sheriff T; Daniel BS; Murrell DF, 2021, 'Impact of COVID-19 on inpatient dermatology consults in an Australian tertiary hospital', Australasian Journal of Dermatology, 62, pp. 427 - 428, http://dx.doi.org/10.1111/ajd.13649

Ho G; Sheriff T; Doria-Ruiz M; Loh Y; Murrell DF, 2021, 'Are biosimilars for pemphigus safe?', Clinical and Experimental Dermatology, 46, pp. 942 - 943, http://dx.doi.org/10.1111/ced.14610

Murrell DF; Joly P; Werth VP, 2021, 'Individual patients’ risk factors impact guidelines for prophylactic agents used in pemphigus patients treated with rituximab', Journal of the American Academy of Dermatology, 85, pp. e47 - e48, http://dx.doi.org/10.1016/j.jaad.2021.03.018

Silverberg JI; Pinter A; Alavi A; Lynde C; Bouaziz JD; Wollenberg A; Murrell DF; Alpizar S; Laquer V; Chaouche K; Ahmad F; Armstrong JM; Piketty C, 2021, 'Nemolizumab is associated with a rapid improvement in atopic dermatitis signs and symptoms: subpopulation (EASI ≥ 16) analysis of randomized phase 2B study', Journal of the European Academy of Dermatology and Venereology, 35, pp. 1562 - 1568, http://dx.doi.org/10.1111/jdv.17218

Montagnon CM; Tolkachjov SN; Murrell DF; Camilleri MJ; Lehman JS, 2021, 'Subepithelial autoimmune blistering dermatoses: Clinical features and diagnosis', Journal of the American Academy of Dermatology, 85, pp. 1 - 14, http://dx.doi.org/10.1016/j.jaad.2020.11.076

Montagnon CM; Lehman JS; Murrell DF; Camilleri MJ; Tolkachjov SN, 2021, 'Subepithelial autoimmune bullous dermatoses disease activity assessment and therapy', Journal of the American Academy of Dermatology, 85, pp. 18 - 27, http://dx.doi.org/10.1016/j.jaad.2020.05.161

Kasperkiewicz M; Schmidt E; Amagai M; Fairley JA; Joly P; Murrell DF; Payne AS; Yale ML; Zillikens D; Woodley DT, 2021, 'Updated international expert recommendations for the management of autoimmune bullous diseases during the COVID-19 pandemic', Journal of the European Academy of Dermatology and Venereology, 35, pp. e412 - e414, http://dx.doi.org/10.1111/jdv.17207

Murrell DF; Paul CF, 2021, 'What instruments should we add to our toolbox for measuring the severity and control of eczema?', British Journal of Dermatology, 185, pp. 13 - 14, http://dx.doi.org/10.1111/bjd.20398

Montagnon CM; Tolkachjov SN; Murrell DF; Camilleri MJ; Lehman JS, 2021, 'Intraepithelial autoimmune blistering dermatoses: Clinical features and diagnosis', Journal of the American Academy of Dermatology, 84, pp. 1507 - 1519, http://dx.doi.org/10.1016/j.jaad.2020.11.075

Montagnon CM; Lehman JS; Murrell DF; Camilleri MJ; Tolkachjov SN, 2021, 'Intraepithelial autoimmune bullous dermatoses disease activity assessment and therapy', Journal of the American Academy of Dermatology, 84, pp. 1523 - 1537, http://dx.doi.org/10.1016/j.jaad.2021.02.073

Murrell DF; Murase JE, 2021, 'The International Reach of the International Journal of Women's Dermatology and the Women's Dermatologic Society', International Journal of Women's Dermatology, 7, pp. 235 - 236, http://dx.doi.org/10.1016/j.ijwd.2021.05.004

Ramirez-Quizon M; Murrell DF, 2021, 'Managing epidermolysis bullosa during the coronavirus pandemic: Experience and ideals', Clinics in Dermatology, 39, pp. 369 - 373, http://dx.doi.org/10.1016/j.clindermatol.2021.01.014

Lincoln V; Chao L; Woodley DT; Murrell D; Kim M; O'Toole EA; Ly A; Cogan J; Mosallaei D; Wysong A; Chen M, 2021, 'Over-expression of stromal periostin correlates with poor prognosis of cutaneous squamous cell carcinomas', Experimental Dermatology, 30, pp. 698 - 704, http://dx.doi.org/10.1111/exd.14281

Viti G; Forcella C; Feliciani C; Murrell DF, 2021, 'Beyond the skin: Disease parameters in pemphigus', Italian Journal of Dermatology and Venereology, 156, pp. 147 - 150, http://dx.doi.org/10.23736/S2784-8671.21.06678-5

Rogers CL; Gibson M; Kern JS; Martin LK; Robertson SJ; Daniel BS; Su JC; Murrell OGC; Feng G; Murrell DF, 2021, 'A comparison study of outcome measures for epidermolysis bullosa: Epidermolysis Bullosa Disease Activity and Scarring Index (EBDASI) and the Instrument for Scoring Clinical Outcomes of Research for Epidermolysis Bullosa (iscorEB)', JAAD International, 2, pp. 134 - 152, http://dx.doi.org/10.1016/j.jdin.2020.12.007

Murase JE; Murrell DF, 2021, 'Heralding change within dermatology: Response of the International Journal of Women's Dermatology (IJWD) to the twin pandemic of racism', International Journal of Women's Dermatology, 7, pp. 125 - 126, http://dx.doi.org/10.1016/j.ijwd.2021.03.008

Krueger JG; Murrell DF; Garcet S; Navrazhina K; Lee PC; Muscianisi E; Blauvelt A, 2021, 'Secukinumab lowers expression of ACE2 in affected skin of patients with psoriasis', Journal of Allergy and Clinical Immunology, 147, pp. 1107 - 1109.e2, http://dx.doi.org/10.1016/j.jaci.2020.09.021

Daniel BS; Murrell DF, 2021, 'The role of women as past and present advocates for vaccinations: Relevance in the COVID-19 setting', International Journal of Women's Dermatology, 7, pp. 228 - 229, http://dx.doi.org/10.1016/j.ijwd.2020.10.001

Murrell DF; Cheesborough J; Woodley DT, 2021, 'Obituary: Vale Robert Alan Briggaman MD 1934-2020', BRITISH JOURNAL OF DERMATOLOGY, 184, pp. 379 - 380, http://dx.doi.org/10.1111/bjd.19404

Shakshouk H; Daneshpazhooh M; Murrell DF; Lehman JS, 2021, 'Authors' reply to the comment “Treatment considerations for patients with pemphigus during the COVID-19 pandemic”', Journal of the American Academy of Dermatology, 84, pp. e61 - e62, http://dx.doi.org/10.1016/j.jaad.2020.09.002

Barua DP; Chowdhury MIH; Mowla MR; Reich A; Murrell D; Ruzicka T, 2021, 'Comparison of effectiveness of topical tacrolimus 0.1% vs topical halobetasol propionate 0.05% as an add-on to oral hydroxychloroquine in discoid lupus erythematosus', Dermatologic Therapy, 34, http://dx.doi.org/10.1111/dth.14675

Sheriff T; Dickenson-Panas H; Murrell DF, 2021, 'Conducting dermatology clinical trials during the COVID-19 pandemic', Clinics in Dermatology, 39, pp. 104 - 106, http://dx.doi.org/10.1016/j.clindermatol.2020.12.019

Sabourirad S; Peera MR; Wilcsek G; Murrell DF, 2021, 'Ectropion surgery might not be a long-term solution for harlequin ichthyosis', Dermatologic Therapy, 34, http://dx.doi.org/10.1111/dth.14646

Rogers C; Gibson M; Kern JS; Martin LK; Robertson SJ; Su JC; Daniel BS; Murrell DF, 2021, '157 A comparison study of Outcome Measures for Epidermolysis Bullosa; Epidermolysis Bullosa Disease Activity and Scarring Index (EBDASI) and the Instrument for Scoring Clinical Outcomes of Research for Epidermolysis Bullosa (iscorEB)', Journal of Investigative Dermatology, 141, pp. S28 - S28, http://dx.doi.org/10.1016/j.jid.2021.02.177

Back to profile page